Combination Of Idasanutlin, Venetoclax And Obinutuzumab In Patients With Relapsed Or Refractory (R/R) Non-Hodgkin Lymphoma (Nhl): Results From A Phase I/Ii Study
BLOOD(2020)
摘要
Background
更多查看译文
关键词
lymphoma,obinutuzumab,idasanutlin,venetoclax,non-hodgkin
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要